Usefulness of the Baseline Syntax Score to Predict 3-Year Outcome After Complete Revascularization by Percutaneous Coronary Intervention

Park, 2013, Usefulness of the SYNTAX and clinical SYNTAX scores in predicting clinical outcome after unrestricted use of sirolimus- and everolimus-eluting stents, Circ J, 77, 2912, 10.1253/circj.CJ-13-0645 Farooq, 2013, Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score, Circulation, 128, 141, 10.1161/CIRCULATIONAHA.113.001803 Park, 2014, Am Heart J, 167, 384, 10.1016/j.ahj.2013.09.015 Conti, 2015, Coronary occlusion and ischemia reduction, JACC Cardiovasc Interv, 8, 1129, 10.1016/j.jcin.2015.03.021 Vieira, 2012, Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial, Circulation, 126, S158, 10.1161/CIRCULATIONAHA.111.084236 Chung, 2012, Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era, Circ J, 76, 1624, 10.1253/circj.CJ-11-1285 Ranucci, 2009, Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony, Circulation, 119, 3053, 10.1161/CIRCULATIONAHA.108.842393 Serruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626 Park, 2011, Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus versus Cypher to Reduce Late Loss after Stenting) randomized trial, J Am Coll Cardiol, 58, 1844, 10.1016/j.jacc.2011.07.031 Zimarino, 2016, Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: a meta-analysis of randomized and observational studies, Catheter Cardiovasc Interv, 87, 3, 10.1002/ccd.25923 Silber, 2013, Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program, JACC Cardiovasc Interv, 6, 357, 10.1016/j.jcin.2012.11.006 Muntner, 2011, Predictors of low clopidogrel adherence following percutaneous coronary intervention, Am J Cardiol, 108, 822, 10.1016/j.amjcard.2011.04.034 Park, 2012, Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention, Heart, 98, 1366, 10.1136/heartjnl-2012-301892 Becker, 2010, Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions, Am J Cardiol, 106, S2, 10.1016/j.amjcard.2010.08.026 Brugaletta, 2012, Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery disease, JACC Cardiovasc Imaging, 5, S119, 10.1016/j.jcmg.2011.12.009 Stone, 2011, A prospective natural-history study of coronary atherosclerosis, N Engl J Med, 364, 226, 10.1056/NEJMoa1002358 Kubo, 2010, The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization, J Am Coll Cardiol, 55, 1590, 10.1016/j.jacc.2009.07.078 Cassese, 2014, Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography, Heart, 100, 153, 10.1136/heartjnl-2013-304933 Zhao, 2013, Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial, JACC Cardiovasc Imaging, 6, 86, 10.1016/j.jcmg.2012.08.010 Calvert, 2011, Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study, JACC Cardiovasc Imaging, 4, 894, 10.1016/j.jcmg.2011.05.005 Girasis, 2011, Eur Heart J, 32, 3115, 10.1093/eurheartj/ehr369 Singh, 2004, Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions, J Am Coll Cardiol, 44, 357, 10.1016/j.jacc.2004.03.059 Wykrzykowska, 2010, Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial, J Am Coll Cardiol, 56, 272, 10.1016/j.jacc.2010.03.044